Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Share price


Stock Report

Agios Pharmaceuticals Inc AGIO

Last Price
$46.77

Day Change
-2.53|-5.13%

As of 19/07/2019
17:54:50 EDT | USD
Minimum 15 Minutes Delay.

Last Close49.30
Day Range46.52 - 49.42
Mkt Cap2.75Bil
52-Wk Range41.63 - 94.39
Yield %-
ISINUS00847X1046
Volume894,024
P/E-7.81
P/S23.47
P/CF-8.80

Share Price

Financials
201620172018
More ...
Income Statement
Revenue69.8943.0194.39
Operating Income-200.99-320.79-362.48
Net Income-198.47-314.67-346.03
Basic EPS-5.07-6.75-6.03
Avg. Diluted Shares Outstanding394757
Balance Sheet
Current Assets559.89445.26613.78
Non Current Assets59.20169.14244.68
Total Assets619.09614.40858.46
Current Liabilities88.4394.9493.50
Total Liabilities260.50238.89170.92
Total Equity358.59375.50687.54
Cash Flow
Operating Cash Flow38.56-285.23-304.42
Capital Expenditure-9.92-4.63-6.99
Free Cash Flow28.65-289.86-311.41

In millions, except "Basic EPS". Currency is USD.

Company Profile

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

482
Key Stats
More ...
Price/Earning TTM-8.23
Price/Book4.67
Price/Sales TTM24.73
Rev Growth (3 year avg)16.88
EPS Growth (3 year avg)-
Operating Margin % TTM-384.03
Net Margin % TTM-366.61
ROE TTM-65.10
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.